REVANCE THERAPEUTICS INCREVANCE THERAPEUTICS INCREVANCE THERAPEUTICS INC

REVANCE THERAPEUTICS INC

No trades
See on Supercharts

Price target

8.610.000.00%
The 7 analysts offering 1 year price forecasts for RTI have a max estimate of — and a min estimate of —.

Analyst rating

Based on 9 analysts giving stock ratings to RTI in the past 3 months.

EPS

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise

Revenue

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions


RTI EPS for the last quarter is −0.33 EUR despite the estimation of −0.24 EUR. In the next quarter EPS is expected to reach −0.18 EUR. Track more of REVANCE THERAPEUTICS INC financials and stay on top of what is up with the company.
In the next quarter REVANCE THERAPEUTICS INC revenue is expected to reach ‪78.44 M‬ EUR. Check out REVANCE THERAPEUTICS INC revenue and earnings and make informed decisions.
According to analysts, RTI price target is 8.61 EUR with a max estimate of 23.32 EUR and a min estimate of 5.60 EUR. Check if this forecast comes true in a year, meanwhile watch REVANCE THERAPEUTICS INC stock price chart and keep track of the current situation with RTI news and stock market news.
We've gathered opinions of 9 analysts rating RTI stock in the past 3 months. Most of them backed up the neutral trend, and after taking into account other opinions, the overall rating was calculated as neutral. Note that it's not a trading advice — your own analysis is still required.